Steven Hager

A randomized phase II study of the telomerase inhibitor imetelstat as maintenance therapy for advanced non-small-cell lung cancer

Alberto Chiappori, Tatjana Kolevska, David R. Spigel et al. · Annals of Oncology · 2014 · 177 citations · Full text

Telomerase Inhibitor Imetelstat, Medicine, Pharmacology +7

Carboplatin plus Gemcitabine Repeating Doublet Therapy in Recurrent Breast Cancer

Robert Alan Nagourney, Marshall S. Flam, John S. Link et al. · Clinical Breast Cancer · 2008 · 22 citations

Breast Oncology, Medicine, Recurrent Breast Cancer +4

Garsorasib, a KRAS G12C inhibitor, with or without cetuximab, an EGFR antibody, in colorectal cancer cohorts of a phase II trial in advanced solid tumors with KRAS G12C mutation

Dan‐Yun Ruan, Haoxiang Wu, Ye Xu et al. · Signal Transduction and Targeted Therapy · 2025 · 12 citations · Full text

An open‐label, dose‐ranging study of Rolontis, a novel long‐acting myeloid growth factor, in breast cancer

Jeffrey Vacirca, Arlene Chan, Klára Mezei et al. · Cancer Medicine · 2018 · 11 citations · Full text

Replacement of ixazomib for relapsed/refractory multiple myeloma patients refractory to a bortezomib or carfilzomib-containing combination therapy.

James R. Berenson, Alexa Cohen, Tanya M. Spektor et al. · Journal of Clinical Oncology · 2017 · 11 citations

Ixz Maximum, Carfilzomib-containing Combination Therapy, Pharmacotherapy +16